Atopic Dermatitis (AD) Clinical Trials

19 recruiting

Atopic Dermatitis (AD) Trials at a Glance

18 actively recruiting trials for atopic dermatitis (ad) are listed on ClinicalTrialsFinder across 6 cities in 13 countries. The largest study group is Phase 1 with 8 trials, with the heaviest enrollment activity in Las Vegas, Fort Lauderdale, and Auburn Hills. Lead sponsors running atopic dermatitis (ad) studies include Attovia Therapeutics Inc, Bluefin Biomedicine, Inc., and Arcutis Biotherapeutics, Inc..

Browse atopic dermatitis (ad) trials by phase

Treatments under study

About Atopic Dermatitis (AD) Clinical Trials

Looking for clinical trials for Atopic Dermatitis (AD)? There are currently 19 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Atopic Dermatitis (AD) trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Atopic Dermatitis (AD) clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 118 of 18 trials

Recruiting
Phase 2

A Study Evaluating BFB759 in Moderate to Severe Atopic Dermatitis

Atopic Dermatitis (AD)
Bluefin Biomedicine, Inc.225 enrolled55 locationsNCT07105488
Recruiting
Phase 1

A Phase 1 Study of GS101 Injection

Atopic Dermatitis (AD)
Jiangsu Genscend Biopharmaceutical Co., Ltd294 enrolled1 locationNCT07411755
Recruiting
Phase 2

Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis

Atopic Dermatitis (AD)
Enveda Therapeutics60 enrolled17 locationsNCT07298395
Recruiting
Phase 1

Clinical Evaluation of Skin Microbiome an Over-The-Counter (OTC) Drug for Atopic Dermatitis

Atopic Dermatitis (AD)
Good Molecules, LLC36 enrolled1 locationNCT07146971
Recruiting
Phase 1

Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234

EczemaAtopic Dermatitis (AD)
Arcutis Biotherapeutics, Inc.125 enrolled1 locationNCT07453602
Recruiting
Phase 1

The Impact of Botox on Neuroimmune Interactions in Atopic Dermatitis

Atopic Dermatitis (AD)
Daniel Kaplan8 enrolled2 locationsNCT06928246
Recruiting
Phase 1

Clinical Study to Evaluate the Safety, Pharmacokinetics and Efficacy of VC005 in Adolescent Subjects With Mild to Moderate Atopic Dermatitis

Atopic Dermatitis (AD)
Jiangsu vcare pharmaceutical technology co., LTD10 enrolled1 locationNCT07329101
Recruiting
Phase 1

Safety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and Psoriasis

Psoriasis (PsO)Atopic Dermatitis (AD)
LAPIX Therapeutics Inc.48 enrolled3 locationsNCT06982352
Recruiting
Phase 1

A Phase 1/1b Study to Evaluate Safety, Tolerability and Pharmacokinetics of ZL-1503 in Healthy Volunteers and Participants With Moderate to Severe Atopic Dermatitis

Atopic Dermatitis (AD)
Zai Lab (Shanghai) Co., Ltd.84 enrolled1 locationNCT07235384
Recruiting
Not Applicable

Birth Cohort: Development of IgE Autoantibodies in Newborns With (High Risk of) Atopic Dermatitis

Atopic Dermatitis (AD)AutoantibodyAuto-Immunity+1 more
Universitair Ziekenhuis Brussel500 enrolled1 locationNCT07316465
Recruiting
Not Applicable

Effect of Partially Hydrolyzed Formula With Synbiotics on Skin Barrier Function

Atopic Dermatitis (AD)
Société des Produits Nestlé (SPN)400 enrolled23 locationsNCT06943469
Recruiting
Not Applicable

Effect of an Emollient Cream Containing a Milk Bioactive Peptide on Clinical Signs, Pruritus and Bacterial Colonization of Mild Atopic Dermatitis Skin Lesions in Pediatric Population

Atopic Dermatitis (AD)
Universidad Autónoma de Aguascalientes20 enrolled1 locationNCT07259343
Recruiting
Phase 1

Safety, Tolerability and PK of ATTO-3712 in Healthy Volunteers and Patients With Atopic Dermatitis

Atopic Dermatitis (AD)Normal Volunteers
Attovia Therapeutics Inc72 enrolled1 locationNCT07205081
Recruiting
Phase 2

A Long-term Safety and Efficacy Study Evaluating CM512 in Atopic Dermatitis.

Atopic Dermatitis (AD)
Keymed Biosciences Co.Ltd246 enrolled1 locationNCT07230483
Recruiting
Not Applicable

CeraVe Effect on Restoring Skin Hydration as Maintenance Regimen in Subjects With Mild to Moderate Atopic Dermatitis

Atopic Dermatitis (AD)
Societa Italiana di Dermatologia Medica, Chirurgica, Estetica e di Malattie Sessualmente Trasmesse98 enrolled1 locationNCT07204561
Recruiting

SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY)

Chronic Spontaneous Urticaria (CSU)Hidradenitis Suppurativa (HS)Psoriasis (PsO)+2 more
Leiden University Medical Center840 enrolled8 locationsNCT07021495
Recruiting
Phase 2Phase 3

Herbal Ointment in Treating Atopic Dermatitis Topically

Atopic DermatitisAtopic Dermatitis (AD)
En Chu Kong Hospital66 enrolled1 locationNCT06850311
Recruiting
Phase 2

Phase 2b Safety and Efficacy Study of CGB-500 Topical Ointment with 0.5% and 1% Tofacitnib for Treatment of Atopic Dermatitis

Atopic Dermatitis (AD)
CAGE Bio Inc.180 enrolled16 locationsNCT06810050